Janssen Labs rebranded as JLABS

If you weren’t paying close attention in October, you may have missed a fairly significant shift in the local biotech space. What had been known as Janssen Labs since its opening in 2012 changed its name — and mostly just that — to JLABS to better identify the purpose of the incubator space and create more cohesion under the Johnson & Johnson Innovation umbrella.


ResMed has strong number, China acquisition

ResMed Inc. (NYSE: RMD) continued to post strong numbers in the second quarter and has strengthened its commitment in China as well.


La Jolla Institute board elects two

The La Jolla Institute for Allergy and Immunology has announced that Larry Spitcaufsky and Hunt Pettit have been elected to its board of directors.


Suneva Medical raises $35.4 million


BioMed continues to post strong earnings


Richard Butcher awarded Practitioner of the Year


Qualcomm sells office building on Campus Point for $105M


Ignyta reaches milestone for tumor fighting drug


Cytori names Hayden as general counsel


Otonomy initiates phase 2 trial for AuriPro

Other Health Headlines:

The last-minute phone call that spurred Teva-Allergan deal

The chief executive officer of Teva Pharmaceuticals Industries Ltd., Erez Vigodman, was just hours away from increasing his hostile bid for Mylan Inc. when he got the news he’d waited months to hear. Brent Saunders, his counterpart at Botox-maker Allergan Plc, told him: Forget Mylan. Let’s do lunch.

American Specialty Health appoints Bonhomme as CTO

Jerome Bonhomme has joined American Specialty Health Inc. as chief technology officer.

Mega-health deals bloom in July; Anthem bids $48B for Cigna

NEW YORK — Anthem is buying rival Cigna for $48 billion in a deal that would create the nation's largest health insurer by enrollment, covering about 53 million U.S patients.

Contamination report on water aquifers withheld

California oil-and-gas regulators have refused for nearly a year to release findings of what they termed a “highest-priority” investigation of possible oilfield contamination into the water aquifers that serve millions of people in and around Los Angeles.

Biogen Data Complicates Quest to Slow Alzheimer’s Disease

(Bloomberg) -- Biogen Inc.’s experimental drug for Alzheimer’s disease failed to show a statistically significant cognitive benefit for patients on a closely watched dose, complicating the company’s quest to develop a treatment.

More Health News

Health Videos

Interview with Shelley Lyford, Paul Downey

July 16, 2015 -- George Chamberlin speaks with Shelley Lyford, CEO of West Health, and Paul Downey, president and CEO of Serving Seniors, about participating in the Conference on Aging in Washington, D.C., and the various issues addressed.

Newsmaker Videos

Dick Crowley, Kitchell Contractors Inc.

Dick Crowley, Senior VP of Kitchell discusses the Largest Construction Project in San Diego County.

San Diego Stock Exchange

U.S. Markets

Index Value Change
{{name}} {{value}} {{daychange}}
Updated: -/-/---- -:-- --

Interactive Maps

Address, City, or Zip

Around Town

Bankers Hill/Middletown

Bankers Hill/Middletown

Banker's Hill/Midtown is centrally located in the hills above downtown. Residents enjoy a pedestrian friendly environment with restaurants and services close by.